公司资料
Exagen 股价、新闻与催化剂
- 股票代码:
- XGN
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股票表现
6.70 USD (+0.60%)
收盘价
最后更新: 2026年8月17日
116M USD
市值
股价为何变动
As of Aug 17, 2026, XGN closed up 0.60% at $6.70. No new same-company headline was identified in the current news window.
公司概览
Autoimmune Diagnostics
Exagen provides diagnostic testing for autoimmune and rheumatic diseases. Its tests are designed to help clinicians resolve diagnostically complex cases and support ongoing disease management.
AVISE CTD
AVISE CTD is the company's flagship testing service for lupus and other connective-tissue diseases. It combines multiple biomarkers into an integrated result intended to improve diagnostic confidence. Exagen operates a centralized clinical laboratory and markets its AVISE portfolio primarily to rheumatologists. Revenue is generated through reimbursed testing, supported by payer coverage and physician adoption.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。